16 2024.04
[Date of Board Meeting] DATE OF BOARD MEETING
08 2024.04
Monthly Returns Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2024
08 2024.04
Monthly Returns (Revised) Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2023
02 2024.04
[Other - Business Update] VOLUNTARY ANNOUNCEMENT - FDA GRANTS TELITACICEPT FAST TRACK DESIGNATION FOR TREATMENT OF pSS
02 2024.04
[Overseas Regulatory Announcement - Issue of Securities and Related Matters] An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
02 2024.04
[Overseas Regulatory Announcement - Issue of Securities and Related Matters] An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
02 2024.04
[Overseas Regulatory Announcement - Issue of Securities and Related Matters] An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
02 2024.04
[Overseas Regulatory Announcement - Issue of Securities and Related Matters] An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
02 2024.04
[Overseas Regulatory Announcement - Issue of Securities and Related Matters] An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
02 2024.04
[Overseas Regulatory Announcement - Other] An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
08 2024.04
Monthly Returns (Revised) Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2023
08 2024.04
Monthly Returns Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2024
27 2024.03
[Final Results] ANNOUNCEMENT OF ANNUAL RESULTS FOR THE YEAR ENDED DECEMBER 31, 2023
30 2024.01
[Inside Information / Profit Warning / Overseas Regulatory Announcement - Trading Update] INSIDE INFORMATION-ESTIMATED 2023 ANNUAL RESULTS
04 2024.01
Monthly Returns Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2023
05 2023.12
Monthly Returns Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2023
06 2023.11
Monthly Returns Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2023
30 2023.10
[Inside Information / Quarterly Results / Overseas Regulatory Announcement - Trading Update] 2023 THIRD QUARTERLY REPORT
07 2023.10
Monthly Returns Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2023
21 2023.08
[Interim Results] INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2023
19 2022.04
Constitutional Documents ARTICLES OF ASSOCIATION
31 2022.03
Constitutional Documents - ARTICLES OF ASSOCIATION
06 2020.11
Constitutional Documents - ARTICLES OF ASSOCIATION
06 2020.11
SHAREHOLDERS’ COMMUNICATION POLICY
06 2020.11
PROCEDURES FOR SHAREHOLDERS TO NOMINATE AN INDIVIDUAL AS A DIRECTOR OR A SUPERVISOR OF THE COMPANY
06 2020.11
BOARD DIVERSITY POLICY